VKH
GLMD icon

Virtu KCG Holdings’s Galmed Pharmaceuticals GLMD Stock Holding History

Virtu KCG Holdings’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-114
Closed -$100K – 3104
2017
Q1 		$100K Buy
+114
New +$91K ﹤0.01% 2681
2016
Q4 		– Sell
-92
Closed -$73K – 3550
2016
Q3 		$73K Buy
+92
New +$69.4K ﹤0.01% 2718
2015
Q2 		– Sell
-71
Closed -$121K – 3480
2015
Q1 		$121K Buy
+71
New +$107K ﹤0.01% 2599

Other funds holding GLMD

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GL
GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.35B AUM 34.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RFA
Reilly Financial Advisors La Mesa, California $1.35B AUM 22.65% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Virtu KCG Holdings's GLMD Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Galmed Pharmaceuticals (GLMD) in Q2 2017, closing a stake of 114 shares — an estimated $100K sold.

Virtu KCG Holdings first reported a position in GLMD in Q1 2015 and held it in 3 quarters. The position peaked at $121K in Q1 2015. 10 funds tracked by Wall St. Rank hold GLMD as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Galmed Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 114 Galmed Pharmaceuticals shares in Q2 2017, an estimated $100K.
  • Virtu KCG Holdings first reported a position in Galmed Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Virtu KCG Holdings's Galmed Pharmaceuticals position peaked at $121K in Q1 2015.
  • 10 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.